Introduction Semaglutide, a medication initially developed for the treatment of type 2 diabetes, has emerged as a breakthrough in managing obesity and improving cardiovascular health. As a member of the GLP-1 receptor agonist class, Semaglutide mimics a natural hormone in the body that helps regulate blood sugar, suppress appetite, and https://linkdirectory724.com/listings13003415/semaglutide-a-breakthrough-in-managing-diabetes-obesity-and-cardiovascular-health